Key result
Cellular therapies for MI repair target irreversible ischemic injury starting within 20 minutes of severe ischemia.
Requires therapies to address rapid ischemic progression; leaves open optimal cellular delivery protocols.
Despite significant advances in prevention, diagnosis,and treatment, myocardial infarction remains the numberone cause of death in the United States and other industrialized nations. Myocardial infarctions almost alwaysresult from complications of atherosclerosis, typicallyarising when an atherosclerotic plaque ruptures, leadingto thrombotic occlusion of a major coronary artery. Myocardium has one of the highest metabolic rates of anytissue in the body, making it very susceptible to injury byischemia (deprivation of blood flow). Irreversible ischemic injury (defined as cell death occurring despitereperfusion) begins within 20 minutes of severe ischemiain vivo in all species studied. A wavefront of cell deaththen progresses from subendocardium to subepicardium(Reimer et al. 1977; Reimer and Jennings 1979). Thetime to completion of irreversible injury varies withspecies, from 1–2 hours in the mouse (Michael et al.1999) to 3–6 hours in the dog (Reimer and Jennings1979). Although cardiac myocytes are the most ischemiasensitive cell population, prolonged ischemia also killsmost of the fibroblasts and vascular cells in the tissue...
No takes yet. Share an insight, caveat, or question.
Murry et al. (2002) conducted a review in Myocardial Infarction. Cellular Therapies was evaluated. Cellular therapies for myocardial infarct repair target irreversible ischemic injury, which begins within 20 minutes of severe ischemia and progresses from subendocardium to subepicardium.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: